S&P 500 Index
Uncertainty looms as 2025 nears the halfway mark. How to make sure your portfolio is prepared
Stocks have made a recovered from this year’s lows, but uncertainty remains a key theme as the second half of the year approaches – and investors can prepare for it. President Donald Trump’s rollout of sharply higher tariffs in April sent stocks on a wild ride, with the S & P 500 at one point […]
Read More
‘Collateral damage’: Fund managers lobby Congress over Section 899 to avert foreign investors leaving the U.S.
American fund managers are lobbying Congress over a provision tucked inside President Donald Trump’s tax bill that they say could lead to foreign investors “quickly” pulling investments out of the U.S. The “One Big Beautiful Bill Act,” which passed through the U.S. House of Representatives in May, aims to penalize foreign-owned firms operating in the […]
Read More
CNBC Daily Open: ‘Good reports’ from U.S.-China talks could push S&P 500 to new high, analysts say
He Lifeng, China’s vice premier, arrives for trade talks at Lancaster House in London on June 9, 2025. Chris Ratcliffe | Bloomberg | Getty Images Trade negotiators from the U.S. and China have met in London, and talks are expected to continue Tuesday, a source familiar with the situation told CNBC’s Megan Casella. It seems […]
Read More
CNBC Daily Open: If U.S.-China talks go well, analysts think the S&P 500 could hit new high
U.S. Treasury Secretary Scott Bessent (center) at Lancaster House in London, U.K., on Monday, June 9, 2025. Chris Ratcliffe | Bloomberg | Getty Images Trade negotiators from the U.S. and China have met in London, and talks are expected to continue Tuesday, a source familiar with the situation told CNBC’s Megan Casella. At the top […]
Read More
Asia-Pacific markets climb as investors await details of U.S.-China trade talks
Aerial view by drone of Tokyo Cityscape with Tokyo Sky Tree visible in Tokyo city, Japan on sunrise. pongnathee kluaythong | Moment | Getty Images Asia-Pacific markets climbed Tuesday as investors awaited further details on the U.S.-China trade talks, which were slated to continue for a second day. Officials from both countries held trade talks in […]
Read More
Stock futures are little changed as investors await details on U.S.-China trade policy: Live updates
Traders work at the New York Stock Exchange on June 4, 2025. NYSE Stock futures are near flat on Monday night as investors waited for more insight on trade discussions between the U.S. and China. Dow Jones Industrial Average futures add 25 points points, or 0.1%. S&P 500 futures and Nasdaq 100 futures each also […]
Read More
Robinhood shares drop after the online brokerage fails to get the nod to join the S&P 500
In this article HOOD Follow your favorite stocksCREATE FREE ACCOUNT People wait in line for T-shirts at a pop-up kiosk for the online brokerage Robinhood along Wall Street after the company went public with an initial public offering earlier in the day on July 29, 2021 in New York City. Spencer Platt | Getty Images […]
Read More
Asia-Pacific stocks rise as investors await Beijing-Washington trade meeting and China data
China Shenzhen Real444 | E+ | Getty Images Asian markets climbed Monday as investors awaited trade talks between the U.S. and China later in the day, following accusations between the two over breaching deal terms agreed in Geneva last month. Trade tensions are seemingly easing as China has reportedly granted temporary approvals for the export […]
Read More
Two aerospace stocks are deeply overbought and could be due for a pullback
GE Aerospace and Howmet Aerospace are vulnerable to pullbacks after entering deep overbought territory this week. Each stock climbed more than 3% this week, outperforming the S & P 500 ‘s 1.5% gain in the same period. The stocks have come so far so fast that now GE Aerospace and Howmet have the two highest […]
Read More
JPMorgan’s top biotech and pharma picks for the second half
Biopharmaceutical stocks’ underperformance versus the broader market for a third-straight year is an opportunity for investors, according to JPMorgan. Analyst Chris Schott said in the firm’s June outlook for biopharma that the sector’s poor performance can be traced back to concerns over President Donald Trump’s tariffs and his ” most favored nation ” executive order. […]
Read More